Internal Medicine, Cardiovascular Disease · Tacoma, WA
NPI
1386615433
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
1901 South Cedar St, Suite 301
Tacoma, WA, 98405
Phone (504) 988-6113
Groups this clinician bills Medicare through
Medicare paid, 2024
$481K
5,964 services
Medicare patients, 2024
2,373
Average age 76
Drug cost, 2024
$1.5M
10,306 prescriptions
Company payments, 2025
$65.2
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ahmad M Slim was code 93010 (electrocardiogram), 787 times for 693 patients. In total Ahmad M Slim billed 5,964 services in 64 codes, and Medicare paid $481K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-03-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93010 Electrocardiogram | Facility | 787 | 693 | $6.00 | $4,720 |
| 99214 Office E&M - Established | Office | 451 | 336 | $89.82 | $41K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 398 | 101 | $4.47 | $1,780 |
| 76376 CT Scan | Office | 381 | 299 | $19.19 | $7,312 |
| 93306 Echocardiography (TTE/TEE) | Office | 356 | 333 | $140.51 | $50K |
| 93306 Echocardiography (TTE/TEE) | Facility | 331 | 330 | $50.36 | $17K |
| 93356 Echocardiography (TTE/TEE) | Office | 330 | 249 | $27.53 | $9,086 |
| 93000 Electrocardiogram | Office | 236 | 231 | $9.91 | $2,340 |
| 93228 Electrocardiogram | Office | 196 | 189 | $18.05 | $3,538 |
| 93229 Electrocardiogram | Office | 168 | 166 | $664.47 | $112K |
| 76376 CT Scan | Facility | 134 | 134 | $7.00 | $938 |
| 93015 Electrocardiogram | Office | 133 | 133 | $50.64 | $6,735 |
| 93308 Echocardiography (TTE/TEE) | Office | 131 | 97 | $73.51 | $9,630 |
| A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 125 | 63 | $75.00 | $9,374 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 118 | 108 | $12.89 | $1,521 |
By year: 2022 $431K for 5,321 services; 2023 $522K for 5,636 services; 2024 $481K for 5,964 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ahmad M Slim prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,284 prescriptions and refills. In total Ahmad M Slim wrote 10,306 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,284 | 3,496 | 426 | $15K |
| Metoprolol Succinate Generic | 892 | 2,320 | 300 | $14K |
| Rosuvastatin Calcium Generic | 729 | 2,045 | 235 | $16K |
| Bisoprolol Fumarate Generic | 688 | 1,752 | 222 | $17K |
| Carvedilol Generic | 632 | 1,597 | 186 | $5,561 |
| Eliquis Apixaban | 572 | 1,075 | 130 | $619K |
| Candesartan Cilexetil Generic | 450 | 1,149 | 159 | $29K |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 420 | 1,064 | 141 | $4,483 |
| Bumetanide Generic | 285 | 628 | 90 | $7,029 |
| Isosorbide Dinitrate Generic | 266 | 567 | 86 | $12K |
| Lisinopril Generic | 257 | 681 | 83 | $2,155 |
| Clopidogrel Clopidogrel Bisulfate | 256 | 667 | 83 | $2,623 |
| Nitroglycerin Generic | 233 | 287 | 146 | $3,128 |
| Losartan Potassium Generic | 230 | 625 | 73 | $1,974 |
| Xarelto Rivaroxaban | 229 | 508 | 57 | $283K |
Brand drugs: 1,422 claims; generic drugs: 8,884 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ahmad M Slim $65.2 ($65.2 in general payments such as food, travel and fees) from 4 companies. The largest payer was Novartis Pharmaceuticals Corporation with $43.45.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.